Impact of delay in adjuvant oxaliplatin-based chemotherapy for stage III colon cancer.

被引：8
|
作者：
Peixoto, Renata D'Alpino
Kumar, Aalok
Speers, Caroline
Renouf, Daniel John
Kennecke, Hagen F.
Lim, Howard John
Cheung, Winson Y.
Melosky, Barbara L.
Gill, Sharlene
机构：
[1] BC Canc Agcy, Vancouver, BC, Canada
[2] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.3561
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3561
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Real-world tolerance and outcomes of oxaliplatin-based adjuvant chemotherapy for stage III colon cancer-Does dose intensity matter?
    Yoon, Robert
    Wilkinson, Kate
    Gabriel, Gabriel
    Kadaan, Nasreen
    Roberts, Tara
    Lim, Stephanie
    Asghari, Ray
    Lee, Cheok Soon
    Chua, Wei
    Ng, Weng
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2024, 20 (01) : 63 - 70
  • [22] Utilization of adjuvant chemotherapy in "ideal candidates" with stage III colon cancer.
    Soleja, Mohsin
    Goksu, Suleyman Yasin
    Sanford, Nina Niu
    Beg, Muhammad Shaalan
    Kainthla, Radhika
    Sanjeevaiah, Aravind
    Jones, Amy Little
    Farkas, Linda
    Verma, Udit
    Hsieh, David
    Kazmi, Syed Mohammad Ali
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [23] EARLY INITIATION OF ADJUVANT CHEMOTHERAPY IN PATIENTS WITH STAGE III COLON CANCER.
    Baek, S.
    Bae, O.
    Cho, M.
    [J]. DISEASES OF THE COLON & RECTUM, 2011, 54 (05) : E123 - E123
  • [24] phase II study of oxaliplatin-based regimen in relapsed colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy: INSPIRE study
    Kotaka, M.
    Ishibashi, K.
    Satake, H.
    Tsuji, Y.
    Kataoka, M.
    Nakamura, M.
    Nagata, N.
    Sakamoto, J.
    Oba, K.
    Mishima, H.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S101 - S101
  • [25] Phase II study of an oxaliplatin-based regimen for relapsed colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy (INSPIRE study)
    Keiichiro Ishibashi
    Toru Aoyama
    Masahito Kotaka
    Hironaga Satake
    Yasushi Tsuji
    Masato Kataoka
    Masato Nakamura
    Naoki Nagata
    Junichi Sakamoto
    Koji Oba
    Hideyuki Mishima
    [J]. Cancer Chemotherapy and Pharmacology, 2021, 87 : 665 - 672
  • [26] Tumor budding, an important prognostic factor in stage III colon cancer patients treated with oxaliplatin-based chemotherapy
    Basile, D.
    Broudin, C.
    Emile, J-F.
    Falcoz, A.
    Toullec, C.
    Bennouna, J.
    Louvet, C.
    Desrame, J.
    Fratte, S.
    Andre, T.
    Taieb, J.
    Svrcek, M.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S533 - S533
  • [27] Phase II study of an oxaliplatin-based regimen for relapsed colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy (INSPIRE study)
    Ishibashi, Keiichiro
    Aoyama, Toru
    Kotaka, Masahito
    Satake, Hironaga
    Tsuji, Yasushi
    Kataoka, Masato
    Nakamura, Masato
    Nagata, Naoki
    Sakamoto, Junichi
    Oba, Koji
    Mishima, Hideyuki
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2021, 87 (05) : 665 - 672
  • [28] Impact of patient and physician factors on oncologists' recommendations for adjuvant chemotherapy in stage III colon cancer.
    Krzyzanowska, M. K.
    Regan, M. M.
    Powell, M.
    Earle, C. C.
    Weeks, J. C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 313S - 313S
  • [29] Impact of BRCAness on the efficacy of oxaliplatin-based chemotherapy in patients with unresectable pancreatic cancer.
    Kondo, Tomohiro
    Kanai, Masashi
    Kou, Tadayuki
    Sakuma, Tomohiro
    Mochizuki, Hiroaki
    Kamada, Mayumi
    Nakatsui, Masahiko
    Uza, Norimitsu
    Kodama, Yuzo
    Masui, Toshihiko
    Takaori, Kyoichi
    Matsumoto, Shigemi
    Miyake, Hidehiko
    Okuno, Yasushi
    Muto, Manabu
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [30] Impact of pelvis irradiation on toxicity of further oxaliplatin-based chemotherapy in rectal cancer.
    Spalek, Mateusz
    Michalski, Wojciech
    Bujko, Krzysztof
    Wyrwicz, Lucjan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
12345